Home/ Stocks/ ALEC

Alector, Inc. Common Stock

ALEC XNAS

$1.78 +0.05 (+2.64%) ▲ 15-min delayed

Open

$1.84

High

$2.00

Low

$1.74

Volume

1.25M

Market Cap

$203.18M

About Alector, Inc. Common Stock

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 103 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$1.05M	$-22,930,000	$-0.21
FY 2025	$21.05M	$-142,929,000	$-1.39
Q3 2025	$3.26M	$-34,667,000	$-0.34
Q2 2025	$7.87M	$-30,524,000	$-0.30

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for ALEC yet. Check out our latest market news or earnings calendar.

Get ALEC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Alector, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.